ABR-238901
ABR-238901 is an oral, active S100A8/A9 blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE (receptor for advanced glycation end products) and TLR4 (toll-like receptor 4) . ABR-238901 has potential as a compound for the treatment of myocardial infarction (MI) .
Product Specifications
CAS Number
1638200-22-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
394.63
Molecular Formula
C11H9BrClN3O4S
Notes
Research use only, not for human use.
Receptor
TLR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-12621R-APC-Cy5.5 100 µL
PEX14 Polyclonal Antibody, APC-Cy5.5 Conjugated
Sign In for Pricing
View Details 
BNCB2375-100 1x 100 µL
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/2375), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
GTR15139219 1 Vial
Lentiviral human PLSCR1 shRNA (UAS) - Lentiviral human PLSCR1 shRNA (UAS) plasmid
Sign In for Pricing
View Details